E. M. Frantsyants

Ministry of Health of the Russian Federation

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

MА

Marina А. Gusareva

Ministry of Health of the Russian Federation

T Moiseenko

Rostov Research Institute of Oncology

Anna P. Menshenina

Ministry of Health of the Russian Federation

Oleg I. Kit

Rostov Research Institute of Oncology

L. Ya. Rozenko

Rostov Research Institute of Oncology

N. K. Guskova

Ministry of Health of the Russian Federation

Ekaterina V. Verenikina

Ministry of Health of the Russian Federation

D.I. Vodolazhskiy

Rostov Research Institute of Oncology

Cooperative Institutions

Ministry of Health of the Russian Federation

Rostov Research Institute of Oncology

Saint Petersburg Mining University

Rostov State Medical University

National Medical Research Center of Cardiology

Russian Academy of Sciences

Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Institute of Molecular Pathology and Pathomorphology

Vladivostok State Medical University

Federal Scientific Center of the East Asia Terrestrial Biodiversity FEB RAS

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Possibilities of using dendritic cell vaccine in treatment of radiation injury of the bladder

Cancer Urology (2019)

Oleg I. Kit Anna P. Menshenina L. Ya. Rozenko T Moiseenko E. M. Frantsyants

Background . Radiation therapy for patients with cervical and endometrial cancer is often associated with the development of radiation cystitis which is treated mainly symptomatically. Objective was the rationale for dendritic cell vaccines in the treatment of the bladder damage after radiation therapy. Materials and methods . The treatment effectiveness of late radiation damage to the bladder in 26 oncogynecologic patients after chemoradiotherapy was analyzed in the article. Results . The effectiveness of 25.000.000 autologous dendritic cells vaccine introduced into all the tops of the rhombus of Michaelis for 5 cycles with 2-week intervals was proved. Mucosal erosions, ulcerous defects and telangiectasia during dendritic cell therapy were managed in 100, 81.8 and 78.6 % of cases, respectively, while in control — in 66.7, 50 and 30 % of cases, respectively (p <0.05). One of the mechanisms of action of dendritic cell vaccines in the treatment of radiation injuries may comprise a high phenotypic plasticity of dendritic cells and macrophages and their ability to regulate inflammatory and anti-inflammatory functions and regenerate and repair damaged tissues. Conclusion . The results of treatment for radiation cystitis resistant to the standard anti-inflammatory therapies demonstrate the obvious benefits of immunotherapy.

10.17650/1726-9776-2018-14-4-118-123

Cite

Citations (0)